Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever

BACKGROUND: There is no established treatment of AA amyloidosis, a long-term complication of various chronic inflammatory diseases associated with increased mortality, such as familial Mediterranian fever (FMF). Recently there are few reports pointing out that tocilizumab(TCZ), an anti IL-6 agent ma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Orphanet J Rare Dis
Asıl Yazarlar: Ugurlu, Serdal, Hacioglu, Aysa, Adibnia, Yasaman, Hamuryudan, Vedat, Ozdogan, Huri
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450086/
https://ncbi.nlm.nih.gov/pubmed/28558744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-017-0642-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller